Neurona Therapeutics

Drug Discovery · South San Francisco, CA · Founded 2008 · Privately Held (backing)

Developer of regenerative cell therapies designed for the treatment of chronic neurological disorders. Neurona Therapeutics is based in South San Francisco, CA and was founded in 2008. It is valued at about $1.1 billion as of Oct 2026, set by institutional fund marks. It has raised $348 million across 6 recorded rounds; the latest was a $102 million Series F in Mar 2025.

PMV mark · valuation
$1.1B
Oct 2026
Priced at
a merger or acquisition
Apr 2026
Total raised
$347.6M
Last round
Later Stage VC (Series F)
Mar 2025

Who backs Neurona Therapeutics?

30 investors
InvestorType
Fidelity Management & Research CompanyAsset manager
Viking Global InvestorsAsset manager
National Institutes of HealthOther
University of CaliforniaOther
Alexandria Venture InvestmentsOther
Cormorant Asset ManagementVenture capital
Spur Capital PartnersFund of funds
Berkeley Frontier FundVenture capital
Schroders CapitalOther
Euclidean CapitalFamily office
+ 20 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Neurona Therapeutics investors

30 investors are on record for Neurona Therapeutics, including Fidelity Management & Research Company, Viking Global Investors, National Institutes of Health and University of California. The Series F in Mar 2025 drew 15 investors.

Free account
More of Neurona Therapeutics with a free account
  • ·The complete investor list: 30 names
  • ·Watch Neurona Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 30 firms already write checks for companies like Neurona Therapeutics in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View